XML 73 R61.htm IDEA: XBRL DOCUMENT v3.23.2

Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values - $ / shares	Jan. 24, 2023	Nov. 29, 2022	Jul. 18, 2022	Mar. 31, 2022
Four years [Member]
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values [Line Items]
Fair value at grant date in USD				$ 5.02
Share price at grant date in USD				8.62
Exercise price in USD				$ 8.62
Expected volatility in %				78.46%
Expected life in years				4 years
Expected dividends in %				0.00%
Three years [Member]
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values [Line Items]
Fair value at grant date in USD				$ 4.52
Share price at grant date in USD				8.62
Exercise price in USD				$ 8.62
Expected volatility in %				80.26%
Expected life in years				3 years
Expected dividends in %				0.00%
Two years [Member]
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values [Line Items]
Fair value at grant date in USD				$ 3.87
Share price at grant date in USD				8.62
Exercise price in USD				$ 8.62
Expected volatility in %				82.57%
Expected life in years				2 years
Expected dividends in %				0.00%
One year [Member]
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values [Line Items]
Fair value at grant date in USD				$ 2.26
Share price at grant date in USD				8.62
Exercise price in USD				$ 8.62
Expected volatility in %				65.97%
Expected life in years				1 year
Expected dividends in %				0.00%
Three, Seven Years [Member]
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values [Line Items]
Fair value at grant date in USD			$ 3.91
Share price at grant date in USD			6.72
Exercise price in USD			$ 6.72
Expected volatility in %			79.73%
Expected life in years			3 years 8 months 12 days
Expected dividends in %			0.00%
Two, Seven Years [Member]
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values [Line Items]
Fair value at grant date in USD			$ 3.44
Share price at grant date in USD			6.72
Exercise price in USD			$ 6.72
Expected volatility in %			80.53%
Expected life in years			2 years 8 months 12 days
Expected dividends in %			0.00%
One, Seven Years [Member]
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values [Line Items]
Fair value at grant date in USD			$ 2.67
Share price at grant date in USD			6.72
Exercise price in USD			$ 6.72
Expected volatility in %			76.83%
Expected life in years			1 year 8 months 12 days
Expected dividends in %			0.00%
Zero, Seven Years [Member]
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values [Line Items]
Fair value at grant date in USD			$ 1.63
Share price at grant date in USD			6.72
Exercise price in USD			$ 6.72
Expected volatility in %			71.97%
Expected life in years			8 months 12 days
Expected dividends in %			0.00%
Three,Thirty Four Years [Member]
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values [Line Items]
Fair value at grant date in USD		$ 2.99
Share price at grant date in USD		5.25
Exercise price in USD		$ 5.25
Expected volatility in %		80.80%
Expected life in years		3 years 4 months 2 days
Expected dividends in %		0.00%
Two, Thirty Four Years [Member]
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values [Line Items]
Fair value at grant date in USD		$ 2.6
Share price at grant date in USD		5.25
Exercise price in USD		$ 5.25
Expected volatility in %		82.10%
Expected life in years		2 years 4 months 2 days
Expected dividends in %		0.00%
One, Thirty Four Years [Member]
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values [Line Items]
Fair value at grant date in USD		$ 1.73
Share price at grant date in USD		5.25
Exercise price in USD		$ 5.25
Expected volatility in %		69.24%
Expected life in years		1 year 4 months 2 days
Expected dividends in %		0.00%
Zero, Thirty Three Years [Member]
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values [Line Items]
Fair value at grant date in USD		$ 0.8
Share price at grant date in USD		5.25
Exercise price in USD		$ 5.25
Expected volatility in %		64.72%
Expected life in years		3 months 29 days
Expected dividends in %		0.00%
Three, Eighteen Years [Member]
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values [Line Items]
Fair value at grant date in USD	$ 1.84
Share price at grant date in USD	3.21
Exercise price in USD	$ 3.21
Expected volatility in %	83.34%
Expected life in years	3 years 2 months 4 days
Expected dividends in %	0.00%
Two, EighteenYears [Member]
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values [Line Items]
Fair value at grant date in USD	$ 1.48
Share price at grant date in USD	3.21
Exercise price in USD	$ 3.21
Expected volatility in %	77.63%
Expected life in years	2 years 2 months 4 days
Expected dividends in %	0.00%
One , Eighteen Years [Member]
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values [Line Items]
Fair value at grant date in USD	$ 1
Share price at grant date in USD	3.21
Exercise price in USD	$ 3.21
Expected volatility in %	68.58%
Expected life in years	1 year 2 months 4 days
Expected dividends in %	0.00%
Zero, Eighteen Years [Member]
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of measurement of fair values [Line Items]
Fair value at grant date in USD	$ 0.35
Share price at grant date in USD	3.21
Exercise price in USD	$ 3.21
Expected volatility in %	62.02%
Expected life in years	2 months 4 days
Expected dividends in %	0.00%

X

- References

No definition available.

+ Details

Name:	adse_DisclosureonindividualitemsoftheconsolidatedfinancialstatementsDetailsScheduleofmeasurementoffairvaluesLineItems
Namespace Prefix:	adse_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The number of fair value at grant date per share.

+ References

No definition available.

+ Details

Name:	adse_FairValueAtGrantDateInUSD
Namespace Prefix:	adse_
Data Type:	dtr:perShareItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Share price at grant date in USD.

+ References

No definition available.

+ Details

Name:	adse_SharePriceAtGrantDateInUSD
Namespace Prefix:	adse_
Data Type:	dtr:perShareItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2022-03-24
-Paragraph 47
-Subparagraph a
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_a_i&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The percentage of an expected dividend used to calculate the fair value of share options granted.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2022-03-24
-Paragraph 47
-Subparagraph a
-Clause i
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_a_i&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2022-03-24
-Paragraph 45
-Subparagraph b
-Clause iv
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_b_iv&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
Namespace Prefix:	ifrs-full_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2022-03-24
-Paragraph 45
-Subparagraph d
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_45_d&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	ifrs-full_MeasurementAxis=adse_FourYearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MeasurementAxis=adse_ThreeYearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MeasurementAxis=adse_TwoYearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MeasurementAxis=adse_OneYearMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MeasurementAxis=adse_ThreeSevenYearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MeasurementAxis=adse_TwoSevenYearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MeasurementAxis=adse_OneSevenYearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MeasurementAxis=adse_ZeroSevenYearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MeasurementAxis=adse_ThreeThirtyFourYearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MeasurementAxis=adse_TwoThirtyFourYearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MeasurementAxis=adse_OneThirtyFourYearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MeasurementAxis=adse_ZeroThirtyThreeYearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MeasurementAxis=adse_ThreeEighteenYearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MeasurementAxis=adse_TwoEighteenYearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MeasurementAxis=adse_OneEighteenYearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	ifrs-full_MeasurementAxis=adse_ZeroEighteenYearsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: